Skip to main content
Premium Trial:

Request an Annual Quote

Accelerate Diagnostics Files $150M Shelf Registration

NEW YORK (GenomeWeb News) – Accelerate Diagnostics has filed a shelf registration to publicly offer from time to time up to $150 million of securities.

In a Form S-3 filed with the US Securities and Exchange Commission on Wednesday, the company said that it may offer common stock, preferred stock, debt securities, warrants, and/or units in combination. Net proceeds from any offering will go toward general corporate purposes.

During the summer, Accelerate said that it raised $20 million in a rights offering. Last week, it disclosed in an SEC filing a year over year increase in its third quarter revenues.